Cytotoxic CD8 <sup>+</sup> T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons
2019 · Proceedings of the National Academy of Sciences · 130 citations
https://doi.org/10.1073/pnas.1815961116
N
Nicolas Degauque
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
4.5K
Citations
34
h-index
73
i10-index
Nicolas Degauque is an academic researcher from Inserm. The author has contributed to research in topics: T-cell and B-cell Immunology & Immune Cell Function and Interaction & Renal Transplantation Outcomes and Treatments. The author has an h-index of 34, co-authored 112 publications.
ORCID: 0000-0003-2990-3513Papers by this author
worksAn intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis
2017 · Journal of Autoimmunity · 32 citations
https://doi.org/10.1016/j.jaut.2017.10.005
Blood Gene Signature as a Biomarker for Subclinical Kidney Allograft Rejection: Where Are We?
2024 · Transplantation · 4 citations
https://doi.org/10.1097/tp.0000000000005105
Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients
2011 · Journal of Translational Medicine · 1 citations
https://doi.org/10.1186/1479-5876-9-s2-p25
Natalizumab alters the TCR repertoire after one year of treatment in four MS patients
2011 · Journal of Translational Medicine · 0 citations
https://doi.org/10.1186/1479-5876-9-s2-p26
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat